New advances in CMV and immunosenescence

Experimental Gerontology - Tập 55 - Trang 54-62 - 2014
Paolo Sansoni1, Rosanna Vescovini1, Francesco F. Fagnoni2, Arne Akbar3, Ramon Arens4, Yen-Ling Chiu5, Luka Čičin-Šain6, Julie Dechanet-Merville7, Evelyna Derhovanessian8, Sara Ferrando-Martinez9,10, Claudio Franceschi11, Daniela Frasca12, Tamas Fulöp13, David Furman7,14, Effrossyni Gkrania-Klotsas15, Felicia Goodrum16, Beatrix Grubeck-Loebenstein17, Mikko Hurme18, Florian Kern19, Daniele Lilleri20
1Department of Clinical and Experimental Medicine, University of Parma, Parma, Italy
2Immunohematology and Transfusion Center, Hospital of Parma, Parma, Italy
3Division of Infection and Immunity, University College London, London, United Kingdom
4Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, Leiden, Netherlands
5Institute of Cell Engineering, School of Medicine, Johns Hopkins University, Baltimore, MD, USA
6Department of Vaccinology and Applied Microbiology, Helmholtz Centre for Infection Research, Braunschweig, Germany
7Composantes Innées de la Response Immunitaire et Différenciation, University of Bordeaux, Bordeaux, France
8Department of Internal Medicine II, Center for Medical Research University of Tübingen, Tübingen, Germany
9Laboratorio de InmunoBiología Molecular, Hospital General Universitario Gregorio Marañón and Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain
10Networking Research Center on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Spain
11Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna, Italy
12Department of Microbiology and Immunology, University of Miami Miller School of Medicine, Miami, FL, USA
13Division of Geriatrics and Research Center on Aging, Department of Medicine, Université de Sherbrooke, Sherbrooke, Quebec, Canada
14Department of Microbiology & Immunology, School of Medicine, Stanford University, CA, USA
15Medical Research Council Epidemiology Unit, Cambridge, United Kingdom
16Department of Immunobiology and the Arizona Center on Aging, University of Arizona College of Medicine, Tucson, AZ, USA
17Institute for Biomedical Aging Research, University of Innsbruck, Innsbruck, Austria
18Department of Microbiology and Immunology, University of Tampere, Tampere, Finland
19Division of Medicine, Pathogen Host Interaction (PHI), Brighton and Sussex Medical School, Brighton, United Kingdom
20Laboratori Sperimentali di Ricerca, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy

Tài liệu tham khảo

Barton, 2007, Herpesvirus latency confers symbiotic protection from bacterial infection, Nature, 447, 326, 10.1038/nature05762 Bughio, 2013, An endothelial cell-specific requirement for the UL133–UL138 locus of human cytomegalovirus for efficient virus maturation, J. Virol., 87, 3062, 10.1128/JVI.02510-12 Cicin-Sain, 2012, Cytomegalovirus infection impairs immune responses and accentuates T-cell pool changes observed in mice with aging, PLoS Pathog., 8, e1002849, 10.1371/journal.ppat.1002849 Derhovanessian, 2013, Lower proportion of naive peripheral CD8+ T cells and an unopposed pro-inflammatory response to human Cytomegalovirus proteins in vitro are associated with longer survival in very elderly people, Age (Dordr), 35, 1387, 10.1007/s11357-012-9425-7 Gow, 2013, Cytomegalovirus infection and cognitive abilities in old age, Neurobiol. Aging, 34, 1846, 10.1016/j.neurobiolaging.2013.01.011 Griffiths, 2013, Age-associated increase of low-avidity cytomegalovirus-specific CD8+ T cells that re-express CD45RA, J. Immunol., 190, 5363, 10.4049/jimmunol.1203267 Hertoghs, 2010, Molecular profiling of cytomegalovirus-induced human CD8+ T cell differentiation, J. Clin. Invest., 120, 4077, 10.1172/JCI42758 Kuparinen, 2013, Cytomegalovirus (CMV)-dependent and -independent changes in the aging of the human immune system: a transcriptomic analysis, Exp. Gerontol., 48, 305, 10.1016/j.exger.2012.12.010 Lozza, 2005, Simultaneous quantification of human cytomegalovirus (HCMV)-specific CD4+ and CD8+ T cells by a novel method using monocyte-derived HCMV-infected immature dendritic cells, Eur. J. Immunol., 35, 1795, 10.1002/eji.200526023 Mekker, 2012, Immune senescence: relative contributions of age and cytomegalovirus infection, PLoS Pathog., 8, e1002850, 10.1371/journal.ppat.1002850 Muntasell, 2013, Adaptive reconfiguration of the human NK-cell compartment in response to cytomegalovirus: a different perspective of the host–pathogen interaction, Eur. J. Immunol., 43, 1133, 10.1002/eji.201243117 Pawelec, 2010, Immunosenescence and Cytomegalovirus: where do we stand after a decade?, Immun. Ageing, 7, 13, 10.1186/1742-4933-7-13 Rahbar, 2013, Human cytomegalovirus infection levels in glioblastoma multiforme are of prognostic value for survival, J. Clin. Virol., 57, 36, 10.1016/j.jcv.2012.12.018 Remmerswaal, 2012, Human virus-specific effector-type T cells accumulate in blood but not in lymph nodes, Blood, 119, 1702, 10.1182/blood-2011-09-381574 Roux, 2013, Differential impact of age and cytomegalovirus infection on the gammadelta T cell compartment, J. Immunol., 191, 1300, 10.4049/jimmunol.1202940 Savva, 2013, Cytomegalovirus infection is associated with increased mortality in the older population, Aging Cell, 12, 381, 10.1111/acel.12059 Smithey, 2012, Lifelong persistent viral infection alters the naive T cell pool, impairing CD8 T cell immunity in late life, J. Immunol., 189, 5356, 10.4049/jimmunol.1201867 Solana, 2012, CMV and Immunosenescence: from basics to clinics, Immun. Ageing, 9, 23, 10.1186/1742-4933-9-23 Stragliotto, 2013, Effects of valganciclovir as an add-on therapy in patients with cytomegalovirus-positive glioblastoma: a randomized, double-blind, hypothesis-generating study, Int. J. Cancer, 133, 1204, 10.1002/ijc.28111 Strandberg, 2009, Cytomegalovirus antibody level and mortality among community-dwelling older adults with stable cardiovascular disease, JAMA, 301, 380, 10.1001/jama.2009.4 Sylwester, 2005, Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects, J. Exp. Med., 202, 673, 10.1084/jem.20050882 Terrazzini, 2013, A novel CMV-induced regulatory type T-cell subset increases in older life and links virus-specific immunity to vascular pathology, J. Infect. Dis. Umashankar, 2014, Antagonistic determinants controlling replicative and latent states of human cytomegaovirus infection, J Virol., 10.1128/JVI.03506-13 Vaes, 2010, The BELFRAIL (BFC80+) study: a population-based prospective cohort study of the very elderly in Belgium, BMC Geriatr., 10, 39, 10.1186/1471-2318-10-39 Wall, 2013, Cytomegalovirus seropositivity is associated with increased arterial stiffness in patients with chronic kidney disease, PLoS ONE, 8, e55686, 10.1371/journal.pone.0055686 Wang, 2010, Cytomegalovirus infection and the risk of mortality and frailty in older women: a prospective observational cohort study, Am. J. Epidemiol., 171, 1144, 10.1093/aje/kwq062 Welzl, 2014, How immunosuppressive therapy affects T cells from kidney transplanted patients of different age: the role of latent CMV infection, Clin. Exp. Immunol., 176, 112, 10.1111/cei.12205 Willcox, 2012, Cytomegalovirus and tumor stress surveillance by binding of a human gammadelta T cell antigen receptor to endothelial protein C receptor, Nat. Immunol., 13, 872, 10.1038/ni.2394 Wills, 2011, Report from the second cytomegalovirus and immunosenescence workshop, Immun. Ageing, 8, 10, 10.1186/1742-4933-8-10 Wolmer-Solberg, 2013, Frequent detection of human cytomegalovirus in neuroblastoma: a novel therapeutic target?, Int. J. Cancer., 133, 2351, 10.1002/ijc.28265